MiR-337-3p lowers serum LDL-C level through targeting PCSK9 in hyperlipidemic mice. Xu X, Dong Y, Ma N, Kong W, et al. Metabolism 2021 Mar 25:154768. doi: 10.1016/j.metabol.2021.154768.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xu X, Dong Y, Ma N, Kong W, et al. MiR-337-3p lowers serum LDL-C level through targeting PCSK9 in hyperlipidemic mice. Metabolism 2021 Mar 25:154768. doi: 10.1016/j.metabol.2021.154768.
PMID: 33775647